Moderate riskFDA DrugClass II

AvKARE amitriptyline tablets recalled for failed dissolution

AvKARE is recalling one lot of amitriptyline hydrochloride 10 mg tablets because they failed dissolution specifications. The recall covers 3,534 cartons of 50-count unit dose cards distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All AvKARE recalls

What to do

  1. Talk to your pharmacist or prescriber before stopping it.
  2. Check the carton for lot 48489, expiration date 12/31/2026, and NDC 50268-037-15.
  3. The notice doesn't say how to get a refund or replacement; ask AvKARE or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Amitriptyline Hydrochloride, Tablets, USP, 10 mg, 5 x 10 Unit dose cards in paper cartons, Rx only, Manufactured for AvKARE, Pulaski, TN 38478, NDC 50268-037-15.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
3534 50-count cartons
Illnesses reported
None reported
Manufactured in
615 N 1st St, Pulaski, TN, United States
Classification
Class II
Recall number
100061

In the FDA's words

Description
Amitriptyline Hydrochloride, Tablets, USP, 10 mg, 5 x 10 Unit dose cards in paper cartons, Rx only, Manufactured for AvKARE, Pulaski, TN 38478, NDC 50268-037-15. Failed dissolution specifications. Lot # 48489, Expiry: 12/31/2026 Distribution: US Nationwide. Affected quantity: 3534 50-count cartons
Hazard
Failed dissolution specifications.

More from AvKARE

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug